A diagnostic scoring system for myxedema coma

Geanina Popoveniuc, Tanu Chandra, Anchal Sud, Meeta Sharma, Marc R. Blackman, Kenneth D. Burman, Mihriye Mete, Sameer Desale, Leonard Wartofsky

Research output: Contribution to journalArticle

Abstract

Objective: To develop diagnostic criteria for myxedema coma (MC), a decompensated state of extreme hypothyroidism with a high mortality rate if untreated, in order to facilitate its early recognition and treatment.Methods: The frequencies of characteristics associated with MC were assessed retrospectively in patients from our institutions in order to derive a semiquantitative diagnostic point scale that was further applied on selected patients whose data were retrieved from the literature. Logistic regression analysis was used to test the predictive power of the score. Receiver operating characteristic (ROC) curve analysis was performed to test the discriminative power of the score.Results: Of the 21 patients examined, 7 were reclassified as not having MC (non-MC), and they were used as controls. The scoring system included a composite of alterations of thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic systems, and presence or absence of a precipitating event. All 14 of our MC patients had a score of ≥60, whereas 6 of 7 non-MC patients had scores of 25 to 50. A total of 16 of 22 MC patients whose data were retrieved from the literature had a score ≥60, and 6 of 22 of these patients scored between 45 and 55. The odds ratio per each score unit increase as a continuum was 1.09 (95% confidence interval [CI], 1.01 to 1.16; P = .019); a score of 60 identified coma, with an odds ratio of 1.22. The area under the ROC curve was 0.88 (95% CI, 0.65 to 1.00), and the score of 60 had 100% sensitivity and 85.71% specificity.Conclusion: A score ≥60 in the proposed scoring system is potentially diagnostic for MC, whereas scores between 45 and 59 could classify patients at risk for MC.

Original languageEnglish (US)
Pages (from-to)808-817
Number of pages10
JournalEndocrine Practice
Volume20
Issue number8
DOIs
StatePublished - Aug 1 2014
Externally publishedYes

Fingerprint

Myxedema
Coma
ROC Curve
Odds Ratio
Confidence Intervals
Hypothyroidism
Logistic Models
Regression Analysis
Sensitivity and Specificity
Mortality

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Popoveniuc, G., Chandra, T., Sud, A., Sharma, M., Blackman, M. R., Burman, K. D., ... Wartofsky, L. (2014). A diagnostic scoring system for myxedema coma. Endocrine Practice, 20(8), 808-817. https://doi.org/10.4158/EP13460.OR

A diagnostic scoring system for myxedema coma. / Popoveniuc, Geanina; Chandra, Tanu; Sud, Anchal; Sharma, Meeta; Blackman, Marc R.; Burman, Kenneth D.; Mete, Mihriye; Desale, Sameer; Wartofsky, Leonard.

In: Endocrine Practice, Vol. 20, No. 8, 01.08.2014, p. 808-817.

Research output: Contribution to journalArticle

Popoveniuc, G, Chandra, T, Sud, A, Sharma, M, Blackman, MR, Burman, KD, Mete, M, Desale, S & Wartofsky, L 2014, 'A diagnostic scoring system for myxedema coma', Endocrine Practice, vol. 20, no. 8, pp. 808-817. https://doi.org/10.4158/EP13460.OR
Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD et al. A diagnostic scoring system for myxedema coma. Endocrine Practice. 2014 Aug 1;20(8):808-817. https://doi.org/10.4158/EP13460.OR
Popoveniuc, Geanina ; Chandra, Tanu ; Sud, Anchal ; Sharma, Meeta ; Blackman, Marc R. ; Burman, Kenneth D. ; Mete, Mihriye ; Desale, Sameer ; Wartofsky, Leonard. / A diagnostic scoring system for myxedema coma. In: Endocrine Practice. 2014 ; Vol. 20, No. 8. pp. 808-817.
@article{4ab331a9e2da43b1956ab4349be691a2,
title = "A diagnostic scoring system for myxedema coma",
abstract = "Objective: To develop diagnostic criteria for myxedema coma (MC), a decompensated state of extreme hypothyroidism with a high mortality rate if untreated, in order to facilitate its early recognition and treatment.Methods: The frequencies of characteristics associated with MC were assessed retrospectively in patients from our institutions in order to derive a semiquantitative diagnostic point scale that was further applied on selected patients whose data were retrieved from the literature. Logistic regression analysis was used to test the predictive power of the score. Receiver operating characteristic (ROC) curve analysis was performed to test the discriminative power of the score.Results: Of the 21 patients examined, 7 were reclassified as not having MC (non-MC), and they were used as controls. The scoring system included a composite of alterations of thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic systems, and presence or absence of a precipitating event. All 14 of our MC patients had a score of ≥60, whereas 6 of 7 non-MC patients had scores of 25 to 50. A total of 16 of 22 MC patients whose data were retrieved from the literature had a score ≥60, and 6 of 22 of these patients scored between 45 and 55. The odds ratio per each score unit increase as a continuum was 1.09 (95{\%} confidence interval [CI], 1.01 to 1.16; P = .019); a score of 60 identified coma, with an odds ratio of 1.22. The area under the ROC curve was 0.88 (95{\%} CI, 0.65 to 1.00), and the score of 60 had 100{\%} sensitivity and 85.71{\%} specificity.Conclusion: A score ≥60 in the proposed scoring system is potentially diagnostic for MC, whereas scores between 45 and 59 could classify patients at risk for MC.",
author = "Geanina Popoveniuc and Tanu Chandra and Anchal Sud and Meeta Sharma and Blackman, {Marc R.} and Burman, {Kenneth D.} and Mihriye Mete and Sameer Desale and Leonard Wartofsky",
year = "2014",
month = "8",
day = "1",
doi = "10.4158/EP13460.OR",
language = "English (US)",
volume = "20",
pages = "808--817",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "8",

}

TY - JOUR

T1 - A diagnostic scoring system for myxedema coma

AU - Popoveniuc, Geanina

AU - Chandra, Tanu

AU - Sud, Anchal

AU - Sharma, Meeta

AU - Blackman, Marc R.

AU - Burman, Kenneth D.

AU - Mete, Mihriye

AU - Desale, Sameer

AU - Wartofsky, Leonard

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Objective: To develop diagnostic criteria for myxedema coma (MC), a decompensated state of extreme hypothyroidism with a high mortality rate if untreated, in order to facilitate its early recognition and treatment.Methods: The frequencies of characteristics associated with MC were assessed retrospectively in patients from our institutions in order to derive a semiquantitative diagnostic point scale that was further applied on selected patients whose data were retrieved from the literature. Logistic regression analysis was used to test the predictive power of the score. Receiver operating characteristic (ROC) curve analysis was performed to test the discriminative power of the score.Results: Of the 21 patients examined, 7 were reclassified as not having MC (non-MC), and they were used as controls. The scoring system included a composite of alterations of thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic systems, and presence or absence of a precipitating event. All 14 of our MC patients had a score of ≥60, whereas 6 of 7 non-MC patients had scores of 25 to 50. A total of 16 of 22 MC patients whose data were retrieved from the literature had a score ≥60, and 6 of 22 of these patients scored between 45 and 55. The odds ratio per each score unit increase as a continuum was 1.09 (95% confidence interval [CI], 1.01 to 1.16; P = .019); a score of 60 identified coma, with an odds ratio of 1.22. The area under the ROC curve was 0.88 (95% CI, 0.65 to 1.00), and the score of 60 had 100% sensitivity and 85.71% specificity.Conclusion: A score ≥60 in the proposed scoring system is potentially diagnostic for MC, whereas scores between 45 and 59 could classify patients at risk for MC.

AB - Objective: To develop diagnostic criteria for myxedema coma (MC), a decompensated state of extreme hypothyroidism with a high mortality rate if untreated, in order to facilitate its early recognition and treatment.Methods: The frequencies of characteristics associated with MC were assessed retrospectively in patients from our institutions in order to derive a semiquantitative diagnostic point scale that was further applied on selected patients whose data were retrieved from the literature. Logistic regression analysis was used to test the predictive power of the score. Receiver operating characteristic (ROC) curve analysis was performed to test the discriminative power of the score.Results: Of the 21 patients examined, 7 were reclassified as not having MC (non-MC), and they were used as controls. The scoring system included a composite of alterations of thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic systems, and presence or absence of a precipitating event. All 14 of our MC patients had a score of ≥60, whereas 6 of 7 non-MC patients had scores of 25 to 50. A total of 16 of 22 MC patients whose data were retrieved from the literature had a score ≥60, and 6 of 22 of these patients scored between 45 and 55. The odds ratio per each score unit increase as a continuum was 1.09 (95% confidence interval [CI], 1.01 to 1.16; P = .019); a score of 60 identified coma, with an odds ratio of 1.22. The area under the ROC curve was 0.88 (95% CI, 0.65 to 1.00), and the score of 60 had 100% sensitivity and 85.71% specificity.Conclusion: A score ≥60 in the proposed scoring system is potentially diagnostic for MC, whereas scores between 45 and 59 could classify patients at risk for MC.

UR - http://www.scopus.com/inward/record.url?scp=84906554613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906554613&partnerID=8YFLogxK

U2 - 10.4158/EP13460.OR

DO - 10.4158/EP13460.OR

M3 - Article

C2 - 24518183

AN - SCOPUS:84906554613

VL - 20

SP - 808

EP - 817

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 8

ER -